- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01960452
A High Density EEG Comparison of Sleep Patterns in Insomnia
A High Density EEG Comparison of Sleep, Sleep Initiation, and Arousal Patterns in Insomnia Patients and Normal Controls
Study Overview
Detailed Description
Recent advances in electroencephalographic recording techniques have produced new ways to probe the process and function of sleep. Through the use of high-density EEG (hdEEG, up to 256 channels), it is possible to approach the spatial resolution of other brain imaging modalities while affording the millisecond temporal resolution of EEG and providing a direct measure of the underlying brain activity, unlike the indirect and/or secondary biophysical signals of brain hemodynamics/metabolism obtained with PET or SPECT that are suboptimal for exploring the short-lived spatio-temporal dynamics of many brain processes.
Here we used hdEEG to try to characterize topographic changes in sleep EEG expression in individuals with insomnia compared to normal controls. We further used serial awakenings to determine if individuals with insomnia were more likely to subjectively report being awake when they were sleeping, and study instances where a direct confirmation of sleep was followed by a subjective report of wakefulness to see if they are characterized by changes in EEG oscillations.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53719
- University of Wisconsin, Madison
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18-45 years old
- English speaking, reading, and writing
- For control subjects: Insomnia Severity Index (ISI) less than or equal to 6 and does not meet criteria for insomnia
- For insomnia subjects: ISI greater than or equal to 7, meets criteria for insomnia, and reports insomnia symptoms for at least 6 months
Exclusion Criteria:
- Imminent danger to self or others
- Clinical diagnosis of dementia
- Active Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV Axis I disorder or alcohol or drug dependence or abuse
- Other sleep disorders aside from insomnia
- History of significant head trauma or loss of consciousness over 30 minutes
- Regular use of psychotropic medications in past 4 weeks
- Regular tobacco use
- Drinking more than 3 caffeinated beverages per day
- Significant neurological or medical illness
- Pregnant, less than 6 months post-partum, or planning to become pregnant during the study
- Left-handedness
- Body Mass Index (BMI) greater than 40
- Apnea Hypopnea Index (AHI) greater than 10 on Apnea Link
- Mini mental status exam score less than 27
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Primary insomnia
Participants classified as having insomnia through clinical interview, questionnaires, actigraphy, and sleep log data as well as meeting other eligibility criteria.
|
The first study night will be a baseline sleep recording.
The second night will consist of a series of awakenings (using auditory tones) and subsequent periods of falling back asleep in order to examine the cortical dynamics of hyperarousal or other dysfunction during these two critical sleep processes in insomnia.
|
|
Healthy sleeping controls
Participants classified as having healthy sleepy through clinical interview, questionnaires, actigraphy, and sleep log data as well as meeting other eligibility criteria.
|
The first study night will be a baseline sleep recording.
The second night will consist of a series of awakenings (using auditory tones) and subsequent periods of falling back asleep in order to examine the cortical dynamics of hyperarousal or other dysfunction during these two critical sleep processes in insomnia.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
EEG Power During Sleep
Time Frame: Individual night of sleep recorded on average within 4 weeks of enrollment (Night 1, Baseline EEG)
|
The difference in spontaneous NREM sleep (stage N2 or N3) EEG power between subjects with insomnia and good sleeping controls measured with 256 channel high-density EEG equipment.
Reported here is the median spectral power estimated using Welch's method (MATLAB function pwelch) across all 6 second epochs staged by a registered sleep technician as NREM sleep stage N2 or N3 sleep.
The median spectral estimate across all NREM epochs was used to estimate spectral power for each subject as this value is robust to outliers from individual sleep epochs.
The Welch's method done in this way estimates frequency content in .33
Hz bins which are then averaged across the spindle frequency band range (12 - 16Hz) from the approximate CP1 electrode (channel 89).
The value reported below is the MEAN of the median spectral estimate.
Higher values represent more spindle band activity.
This frequency range and location showed the most consistent difference between groups across outcome measures.
|
Individual night of sleep recorded on average within 4 weeks of enrollment (Night 1, Baseline EEG)
|
|
EEG Power Examined Before Arousal From Sleep on Serial Awakening Night
Time Frame: 30 seconds of NREM sleep prior to serial awakening (Night 2, Serial Awakening EEG)
|
The difference in 30 seconds of spontaneous NREM (stage N2 or N3) sleep EEG power prior to serial awakening between subjects with insomnia and good sleeping controls measured with 256 channel high-density EEG equipment.
Reported here is the median spectral power estimated using Welch's method (2 second epochs) of the 30 seconds of NREM sleep stage N2 or N3 sleep immediately prior to the 40dB tone played to initiate a serial awakening sequence.
The median spectral estimate across epochs was used to estimate spectral power for each subject as this value is robust to outliers from individual epochs.
The Welch's method done in this way estimates frequency content in .5 Hz bins which are then averaged across the spindle frequency band range (12 - 16Hz) from the approximate CP1 electrode (channel 89).
Each subject had between 4 - 10 serial awakenings from NREM sleep.
The value reported below is the MEAN of the median spectral estimate.
Higher values represent more spindle band activity.
|
30 seconds of NREM sleep prior to serial awakening (Night 2, Serial Awakening EEG)
|
|
EEG Power Examined as Subjects Fall Asleep on Serial Awakening Night
Time Frame: 30 seconds of falling asleep EEG immediately after the first non-waking epoch following a serial awakening and proceeding 5 minutes of stable sleep (Night 2, Serial Awakening EEG)
|
The difference in 30 seconds of spontaneous falling asleep EEG power between subjects with insomnia and good sleeping controls measured with 256 channel high-density EEG equipment.
Reported here is the median spectral power estimated using Welch's method with 2 second epochs from the 30 seconds of sleep immediately following a serial awakening (starting after the last waking epoch) that resulted in the subject reaching 5 minutes of stable sleep averaged across the spindle frequency band range 12 - 16Hz from the approximate CP1 electrode (channel 89) and across all serial awakening falling asleep periods for each subject.
Each subject had between 4 - 8 falling asleep periods that resulted in 5 minutes of stable sleep within 30 minutes of the serial awakening attempt.
The value reported below is the MEAN of the median spectral estimate.
Higher values represent more spindle band activity.
|
30 seconds of falling asleep EEG immediately after the first non-waking epoch following a serial awakening and proceeding 5 minutes of stable sleep (Night 2, Serial Awakening EEG)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Meredith E Rumble, PhD, University of Wisconsin, Madison
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013-1613
- HSC-2013-0019 (Other Identifier: UW IRB (Tononi))
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
Midnight Pharma, LLCCompletedChronic Primary InsomniaUnited States
-
Oregon Health and Science UniversityCompletedPrimary Insomnia | Psychophysiological InsomniaUnited States
-
University of RochesterSanofi-SynthelaboCompletedInsomnia | Primary Insomnia | Psychophysiologic InsomniaUnited States
-
IWK Health CentreCompletedPrimary Insomnia | Nonorganic InsomniaCanada
-
University of UtahEvans Army Community HospitalCompletedPrimary Insomnia | Secondary InsomniaUnited States
-
US Department of Veterans AffairsCompletedInsomnia | Primary Insomnia | Secondary InsomniaUnited States
-
Jack Edinger, PhDMerck Sharp & Dohme LLCCompletedInsomnia | Primary Insomnia | Chronic InsomniaUnited States
-
University of PittsburghCompletedInsomnia Chronic | Insomnia, PrimaryUnited States
-
University of WashingtonUnknownChronic Insomnia | Insomnia, Primary
Clinical Trials on Serial awakenings
-
University of California, Los AngelesBreast Cancer Research FoundationRecruiting
-
National Eye Institute (NEI)The Emmes Company, LLCCompletedRetinitis PigmentosaUnited States
-
National Eye Institute (NEI)The Emmes Company, LLCCompletedDiabetic Macular EdemaUnited States
-
Wake Forest University Health SciencesAmerican Heart AssociationCompletedChest Pain | Acute Coronary SyndromeUnited States
-
Sun Yat-sen UniversityGuangzhou Burning Rock Dx Co., Ltd.Active, not recruiting
-
Norfolk and Norwich University Hospitals NHS Foundation...University of East AngliaCompleted
-
Centre hospitalier de l'Université de Montréal...Completed
-
Florida State UniversityCompleted
-
John R van NagellRecruiting